Neobiosis Appoints Pascal Goldschmidt, M.D. as Chief Medical Officer
UF Innovate | Sid Martin Biotech resident Neobiosis, a clinical-stage contract development and manufacturing organization, managed by scientists and physicians and focused on the science of regenerative medicine, announced the appointment of Pascal Goldschmidt, M.D. as Chief Medical Officer.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed